Scott Rothbart

15 results.

November 4, 2025 Fighting to outsmart cancer: A Q&A with graduate student Yanqing Liu

Cancers are notorious for finding ways to resist treatment.

Van Andel Institute’s Yanqing Liu, a Ph.D. student in the lab of Scott Rothbart,…

May 19, 2025 Using viral mimicry to help the immune system see — and fight — cancer

Cancer cells are masters of disguise.

Like villains in bad movies, they evade detection by masquerading as healthy cells, turning off the body’s built-in alarm…

April 21, 2025 Pinpointing weaknesses in cancer’s armor

For scientists like Dr. Scott Rothbart, the same strategies that cancer cells use to survive also are powerful opportunities for developing new treatments.  

…

March 27, 2024 Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…

October 20, 2021 Meet the scientist behind the science: Dr. Scott Rothbart

Earlier today, we announced that Van Andel Institute Associate Professor Dr. Scott Rothbart has been awarded a Research Scholar Grant from…

October 20, 2021 American Cancer Society grant to support Van Andel Institute research into anti-cancer medications

GRAND RAPIDS, Mich. (Oct. 20, 2021) — Van Andel Institute’s Scott Rothbart, Ph.D., has earned a four-year, $792,000 Research…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…

November 20, 2020 After more than a decade, ChIP-seq may be quantitative after all

GRAND RAPIDS, Mich. (Nov. 20, 2020) — For more than a decade, scientists studying epigenetics have used a powerful method called ChIP-seq to map changes…